Clinical Trials Logo

Coronary Heart Disease (CHD) clinical trials

View clinical trials related to Coronary Heart Disease (CHD).

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06216847 Not yet recruiting - Clinical trials for Coronary Heart Disease (CHD)

Clinical Outcomes of Patients With Coronary Artery Disease

COCAD
Start date: February 1, 2024
Phase:
Study type: Observational [Patient Registry]

Coronary heart disease (CHD) stands as a foremost contributor to global mortality, characterized by complex pathogenesis that renders conventional "one-size-fits-all" preventive strategies inefficient. Therefore, the investigators designed a prospective, multi-center cohort study among patients hospitalized due to either confirmed or suspected CHD, which aimed to establish a holographic data set for the diagnosis and treatment of CHD and explore the impact of critical therapeutic strategies in the real world on the clinical outcomes of CHD patients, providing evidence to optimize the management pathway.

NCT ID: NCT05178602 Not yet recruiting - Renal Insufficiency Clinical Trials

The Effect of TaiChi on Ischemic Burden of Patients With Coronary Heart Disease Complicated With Renal Insufficiency

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

This study focuses on patients with incomplete revascularization combined with renal insufficiency. And since heart and kidney are two organs influence each other, the study take the mechanism of heart and kidney comorbidity and the risk factors of the two organs.As one of the traditional Chinese sports, Tai Chi is an aerobic exercise combineing movements with static postures, which can significantly improve the aerobic endurance of patients with coronary heart disease. In this study, a parallel, randomized controlled study method is used to quantitatively evaluate the myocardial ischemia condition by myocardial perfusion imaging indicators. This study aims to figure out whether the cardiac rehabilitation training program based on Tai Chi has a positive effect on the patients' myocardial ischemic.